Study of the AnchorMan heart pouch closure device for stroke prevention
Part of Heart & circulation clinical trials.
This study tests a device that is placed in a small pouch of the heart (left atrial appendage) to help prevent strokes in people with atrial fibrillation who cannot take blood thinners safely. The device is already used in some patients; this trial watches how well the heart heals around it over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (an irregular heartbeat) and are 18 or older.
- You are at high risk of stroke and have had bleeding problems, cannot take long-term blood thinners, or have had a stroke despite taking blood thinners.
- You are willing to attend follow-up visits for at least several months after the procedure.
- You have not had a stroke or mini-stroke in the last 30 days.
- You do not have severe heart valve disease or severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called LAmbre™ II that closes off a part of the heart called the left atrial appendage to help prevent strokes in people with atrial fibrillation who cannot take blood thinners.
This trial is testing two ways to guide a procedure that closes a small pouch in the heart to lower the risk of stroke in people with atrial fibrillation. The goal is to see if one method is as good or better than the other.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
This study tests a device and procedure to close off a small pouch in the heart (left atrial appendage) where blood clots can form in people with atrial fibrillation. The goal is to reduce the risk of stroke, possibly lowering the need for long-term blood thinners.
This study compares two ways of closing a small pouch in the heart (the left atrial appendage) to help prevent strokes in people with atrial fibrillation (an irregular heartbeat). One method is less invasive, and the study aims to see if it is as safe and effective as the standard approach.
This trial tests a procedure to close off a small pouch in the heart called the left atrial appendage, which is a common source of blood clots in people with atrial fibrillation. The goal is to lower your stroke risk without needing to take blood thinners long-term.
Hear when a new Non-valvular Atrial Fibrillation (NVAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.